Session » Rheumatoid Arthritis – Clinical Aspects VI: Management of Early Rheumatoid Arthritis
-
Abstract Number: 3149
“Early Use of Subcutaneous MTX Monotherapy Vs. MTX Oral or Combination Therapy Significantly Delays Time to Initiating Biologics in Early RA
-
Abstract Number: 3150
The Initial Dose of Methotrexate per Weight Is Determinant of Disease Activity and Early DAS28 Remission in DMARD-Naive Early Rheumatoid Arthritis Patients Receiving Usual Care
-
Abstract Number: 3151
The Diagnostic and Predictive Value of Anti-Acetylated Peptide Antibodies in RA Patients Starting Methotrexate Treatment
-
Abstract Number: 3152
Rheumatoid Arthritis (RA): Premature Use of Biologics Accelerating in United States (US)